Efficacy of simple uterine artery embolization in the treatment of placenta accreta after vaginal delivery

doi:10.3760/cma.j.issn.1007-1245.2023.11.004

Abstract

Abstract:

Objective　To evaluate the clinical efficacy of simple uterine artery embolization for placenta accreta after vaginal delivery. Methods　A total of 33 patients with placenta accreta after vaginal delivery in Fujian Maternal and Child Health Hospital from January 2017 to December 2021 were retrospectively selected as the subjects, with an age of (31.21±3.64) years old, the number of pregnancies of (3.21±0.68), and the number of births of (0.79±0.12). The diagnosis timing, prenatal management, intrapartum management, postpartum management, and recovery time of human chorionic gonadotropin (HCG) were observed for the patients with placenta accreta after vaginal delivery. The patients' qualities of life before and after treatment were compared. Paired t test was used. Results　The 33 patients received targeted treatment and intervention according to their actual disease conditions at different stages of prenatal, intrapartum, and postpartum, and the time for HCG returning to normal was (35.24±6.13) d. After treatment, the patients' scores of physiological function [(81.09±3.17) points], mental state [(81.16±4.25) points], overall health [(81.34±3.07) points], vitality [(81.29±4.22) points], somatic pain [(83.48±3.08) points], physiological function [(81.56±4.35) points], emotional function [(81.54±4.27) points], and social function [(81.88±3.52) points] were higher than those before treatment [(73.24±4.55) points, (73.17±3.87) points, (73.28±5.43) points, (73.44±4.87) points, (75.49±5.27) points, (73.15±4.88) points, (74.28±3.48) points, and (74.48±3.84) points], with statistically significant differences (t=8.131, 7.985, 7.422, 6.997, 7.519, 7.390, 7.571, and 8.160; all P<0.001). Conclusion　Simple uterine artery embolization can produce ideal clinical efficacy in the treatment of patients with placenta accreta after vaginal delivery, and optimize the quality of life, so it is worthy of popularization and application.

Key words:

Vaginal delivery, Placenta accreta, Uterine artery embolization

摘要：

目的　评估针对阴道分娩后胎盘植入实施单纯子宫动脉栓塞术治疗的临床疗效。方法　回顾性分析2017年1月至2021年12月福建省妇幼保健院阴道分娩后胎盘植入患者33例为研究对象，其中患者年龄（31.21±3.64）岁，孕次（3.21±0.68）次，产次（0.79±0.12）次。观察阴道分娩后胎盘植入患者诊断时机、产前处理、产时处理、产后处理、人绒毛膜促性腺激素（HCG）恢复正常时间，并对比患者治疗前后生活质量变化情况。采用配对t检验。结果　33例患者在产前、产时、产后不同阶段均根据其实际患病情况展开了针对性的治疗与干预，其HCG恢复正常时间为（35.24±6.13）d。治疗后患者生理职能［（81.09±3.17）分］、精神状态［（81.16±4.25）分］、总体健康［（81.34±3.07）分］、活力［（81.29±4.22）分］、躯体疼痛［（83.48±3.08）分］、生理功能［（81.56±4.35）分］、情感职能［（81.54±4.27）分］、社会功能评分［（81.88±3.52）分］均高于治疗前［（73.24±4.55）分、（73.17±3.87）分、（73.28±5.43）分、（73.44±4.87）分、（75.49±5.27）分、（73.15±4.88）分、（74.28±3.48）分、（74.48±3.84）分］，差异均有统计学意义（t=8.131、7.985、7.422、6.997、7.519、7.390、7.571、8.160，均P<0.001）。结论　单纯子宫动脉栓塞术在对阴道分娩后胎盘植入患者实施治疗时，能够产生理想的临床疗效，可优化生活质量，值得推广应用。

关键词:

阴道分娩, 胎盘植入, 子宫动脉栓塞术

Ren Kunhai, Zheng Xiuqiong, Xu Rongli, Lin Jinxiao.

Efficacy of simple uterine artery embolization in the treatment of placenta accreta after vaginal delivery [J]. International Medicine and Health Guidance News, 2023, 29(11): 1494-1497.

任坤海郑秀琼徐榕莉林金孝.

单纯子宫动脉栓塞术治疗阴道分娩后胎盘植入的疗效分析 [J]. 国际医药卫生导报, 2023, 29(11): 1494-1497.

References

[1] 宋丽丽,殷悦,刘丽娟. 子宫动脉栓塞术在凶险性前置胎盘伴胎盘植入剖宫产患者中的应用[J]. 山东医药,2020,60(25):62-65.DOI:10.3969/j.issn.1002- 266X.2020.25.017.
[2] 朱芬菊. 子宫动脉栓塞术治疗凶险性前置胎盘伴胎盘植入的临床效果[J]. 中国农村卫生,2021,13(5):85,87. DOI:10.3969/j.issn.1674-361X.2021.05.046.
[3] 李峰娟. 子宫动脉栓塞术预防孕中期胎盘植入终止妊娠时大出血效果探讨[J]. 中国保健营养,2020,30(5):309.
[4] 黄水玉,涂荧花. 子宫动脉化疗栓塞术和甲氨蝶呤治疗完全性胎盘植入的效果及安全性分析[J]. 海峡药学,2020,32(4):136-138.DOI:10.3969/j.issn.1006-3765.2020.04.050.
[5] 翟丽霞. 子宫动脉栓塞术联合甲氨蝶呤及清宫术治疗胎盘植入患者的临床疗效分析[J]. 现代诊断与治疗,2020,31(18):2947-2948.
[6] 卢大群. DSA引导下双侧髂内动脉球囊预置阻断术与子宫动脉栓塞术对凶险性前置胎盘伴胎盘植入患者的效果比较[J]. 河南医学研究,2021,30(9):1595-1597.DOI:10.3969/j.issn.1004-437X.2021.09.020.
[7] 刘小晖,董燕,刘小玲,等. 止血带联合子宫动脉结扎在凶险性前置胎盘伴重度胎盘植入术中的应用[J]. 实用妇产科杂志,2021,37(3):203-207.
[8] 杨勇,凌冰,韩绪生,等. 腹主动脉球囊预置术和子宫动脉栓塞术在凶险性前置胎盘伴胎盘植入的应用[J]. 医学影像学杂志,2020,30(11):2148-2151.
[9] 徐丽娟,傅向红,纪毅梅,等. 双侧髂内动脉栓塞术联合剖宫产术对凶险性前置胎盘合并胎盘植入产妇围手术期指标、子宫切除率及母婴结局的影响[J]. 中国妇幼保健,2020,35(16):2963-2965.DOI:10.19829/j.zgfybj.issn.1001- 4411.2020.16.009.
[10] 余幼辉,范建辉,黄灿,等. 子宫动脉化疗栓塞联合清宫术治疗阴道分娩后胎盘植入的临床效果[J]. 中国当代医药,2019,26(2):127-130.DOI:10.3969/j.issn.1674-4721. 2019.02.040.
[11] 杨春. 单纯子宫动脉栓塞术治疗阴道分娩后胎盘植入的疗效观察[J]. 中国医师杂志,2015,17(8):1258-1260.DOI:10.3760/cma.j.issn.1008-1372.2015.08.044.
[12] 丁志云,陈友国,丁红梅,等. 子宫动脉栓塞及胎盘原位保留治疗凶险性前置胎盘伴胎盘植入的效果分析[J]. 中国实用医刊,2019,46(13):46-49.DOI:10.3760/cma.j.issn.1674- 4756.2019.13.013.
[13] 钱敏,单楠,漆洪波. 腹主动脉球囊阻断术联合子宫动脉栓塞术对凶险性前置胎盘的治疗效果[J]. 西部医学,2018,30(12):1758-1762.DOI:10.3969/j.issn.1672-3511.2018. 12.009.
[14] 张继红,张禹,胡桂梅. 子宫动脉栓塞术联合甲氨蝶呤及清宫术对胎盘植入患者术后性激素水平及预后的影响[J]. 河南医学研究,2018,27(18):3319-3321.
[15] 刘柳苑,叶思兰,陈俏凤. 超声引导下清宫术联合子宫动脉栓塞术治疗剖宫产后瘢痕妊娠的临床疗效观察[J]. 影像研究与医学应用,2021,5(16):239-240.DOI:10.3969/j.issn.2096-3807.2021.16.114.
[16] 徐欣欣. 子宫动脉栓塞术治疗凶险性前置胎盘的临床效果研究[J]. 系统医学,2021,6(8):126-128.DOI:10.19368/j.cnki.2096-1782.2021.08.126.
[17] 李联,齐秀玲. 子宫动脉栓塞术对凶险性前置胎盘患者凝血系统及母婴结局的影响[J]. 临床医学研究与实践,2021,6(36):115-117.DOI:10.19347/j.cnki.2096- 1413.202136037.
[18] 魏林. 子宫动脉栓塞与子宫动脉结扎治疗凶险性前置胎盘产后出血对比分析[J]. 黑龙江医药科学,2021,44(5):77-78,81.DOI:10.3969/j.issn.1008-0104.2021.05.030.
[19] 叶鹏飞,刘灵军,赵福敏,等. 子宫动脉栓塞术用于胎盘植入性疾病[J]. 中国介入影像与治疗学,2022,19(12):787-790.DOI:10.13929/j.issn.1672-8475.2022.12.013.
[20] 芦婧. 子宫动脉栓塞术治疗中期妊娠前置胎盘出血的效果观察[J]. 中国现代药物应用,2021,15(19):55-57.DOI:10.14164/j.cnki.cn11-5581/r.2021.19.020.